Tag: Cancer
-
Improving Interferon Therapy for Blood Cancers
Northwestern Medicine investigators have discovered a novel signaling pathway activated by interferons, a group of immune system proteins, that suppresses the anti-tumor response of interferons in patients with a particular type of blood cancer, according to findings published in Nature Communications. Targeting this pathway in combination with interferon therapy may provide a novel approach to[…]
-
Improving Interferon Therapy for Blood Cancers
Investigators have discovered a novel signaling pathway in interferons that suppresses their anti-tumor response in patients with a particular type of blood cancer.
-
T-Cell Interactions Vary Between Tumor Microenvironments
A team led by Northwestern Medicine investigators has discovered differences in the distribution and interaction of T-cells within different parts of brain tumor and brain metastasis microenvironments.
-
Investigators Identify Potential Therapeutic Target for Pancreatic Cancer
Investigators discovered that decreased expression of the G alpha 13 protein in mice and human pancreatic tumors promotes tumor growth, according to recent findings.
-
Pathology Chair: Evolution of Brain Tumor Classification
Daniel Brat, MD, PhD, has been heavily involved in the process of moving molecular genetic biomarkers for glioma from the bench to the beside.
-
Transcription Factors Cooperate to Promote Cancer Growth
A well-established cancer cell transcription factor and its newly identified co-factor work together to drive cancer cell proliferation, according to a Northwestern Medicine study published in Science Advances.
-
Racial and Neighborhood Disparities in Breast Cancer
Black women with early hormone receptor-positive breast cancer experienced shorter relapse-free intervals and overall survival compared with white women, according to findings published in JAMA Oncology.
-
Optimizing Balance of Treatments in Prostate Cancer
Patients receiving radiotherapy to treat high-risk prostate cancer benefit from androgen deprivation therapy, and length of treatment may be dependent on radiation deliver, according to a recent study.
-
New Treatment for Metastatic Hormone-Sensitive Prostate Cancer
The drug darolutamid, administered with standard androgen-deprivation therapy and docetaxel chemotherapy, increased survival in patients with metastatic hormone-sensitive prostate cancer.
-
Possible Third Cure To HIV: Progress in a Time of Regression
Associate vice president of research Richard D’Aquila, MD, shares his perspective on the news of a possible third person cured of HIV, and the progress of HIV research in the future.
